GOSSAMER BIO, INC.
Profile
Company Names
GOSSAMER BIO, INC.
Addresses
3013 SCIENCE PARK, SUITE 200, SAN DIEGO, CA 92121
3013 SCIENCE PARK, SAN DIEGO, CA 92121
Phone Numbers
(858) 922-0718
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2015
State Incorporated:
DELAWARE
Total Amount Raised:
$632,627,063.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2023-07-24
$212,102,057.00
$212,102,057.00
$0.00
Equity
3
2022-07-15
$120,041,922.00
$120,041,922.00
$0.00
Equity
2
2018-07-20
$230,015,000.00
$230,015,000.00
$0.00
Equity
1
2018-01-04
$70,468,084.00
$80,000,000.00
$9,531,916.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
KRISTINA
BUROW
DIRECTOR
KILIMANJARO ENERGY, INC.
| LIMERICK BIOPHARMA INC
| RECEPTOS, INC.
| TRELYS, INC.
| CENEXYS, INC.
| LYCERA CORP
| ARCH VENTURE FUND VIII, L.P.
| AGBIOME, LLC
| METACRINE, INC.
| SIENNA LABS, INC.
| SCHOLAR ROCK LLC
| UNITY BIOTECHNOLOGY, INC.
| ARCH VENTURE FUND IX, L.P.
| BORAGEN, INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| SCHOLAR ROCK HOLDING CORP
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| VIVIDION THERAPEUTICS, INC.
| ARCH VENTURE FUND X, L.P.
| ARCH VENTURE FUND X OVERAGE, L.P.
| BOUNDLESS BIO, INC.
| ARCH VENTURE FUND XI, L.P.
| TREELINE BIOSCIENCES, INC.
| ARCH VENTURE FUND XII, L.P.
| NEUMORA THERAPEUTICS, INC.
| MIRADOR THERAPEUTICS, INC.
| AUTOBAHN THERAPEUTICS, INC.
| METSERA, INC.
FAHEEM
HASNAIN
DIRECTOR, EXECUTIVE OFFICER
RICHARD
LIM
DIRECTOR
ADCHINA LTD.
| HYDROCISION INC
| ASPECT GROUP LTD
| SEEO INC
| GSR VENTURES IV, L.P.
| GSR OPPORTUNITIES IV, L.P.
| TRIDENT PHARMACEUTICALS INC
| PARATEK PHARMACEUTICALS INC
| PIPER THERAPEUTICS INC.
| RULAI, INC.
| KINSA INC.
| ZINGBOX, INC.
| MOBISOCIAL, INC
| GOSSAMER BIO, INC.
| GSR 2017 OPPORTUNITIES FUND, L.P.
| SPARTA SOFTWARE CORP
| LOOP NOW TECHNOLOGIES, INC.
| MEDABLE INC.
| DEEP 6 AI INC.
| ALESSA THERAPEUTICS, INC.
ROBERT
NELSEN
DIRECTOR
FORGE INC
| RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)
| AGIOS PHARMACEUTICALS INC
| KILIMANJARO ENERGY, INC.
| NEUROGESX INC
| KYTHERA BIOPHARMACEUTICALS INC
| SYROS PHARMACEUTICALS, INC.
| FATE THERAPEUTICS INC
| CENEXYS, INC.
| JUNO THERAPEUTICS, INC.
| BELLEROPHON THERAPEUTICS LLC
| FARADAY PHARMACEUTICALS, INC.
| SAPPHIRE ENERGY, INC.
| UNITY BIOTECHNOLOGY, INC.
| ARIVALE INC.
| SIENNA BIOPHARMACEUTICALS, INC.
| GOSSAMER BIO, INC.
| VIR BIOTECHNOLOGY, INC.
| BEAM THERAPEUTICS INC.
| GRAIL, INC.
| APEX NEURO HOLDINGS, INC.
| NUTCRACKER THERAPEUTICS, INC.
| SANA BIOTECHNOLOGY, INC.
| INSITRO, INC.
| NATIONAL RESILIENCE, INC.
| MEDICAL CREATIONS, INC.
| NEUMORA THERAPEUTICS, INC.
| RIPPL CARE, INC.
| SEAPORT THERAPEUTICS, INC.
MICHAEL
YI
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2023-07-24
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-07-15
